NCT06706557View on ClinicalTrials.gov

Analysis of Circulating Tumor DNA (ctDNA) in HER2-low Advanced/Metastatic Breast Cancer

RecruitingOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

January 11, 2024

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2030

Conditions
Advanced Metastatic Breast Cancer
Trial Locations (1)

20141

RECRUITING

European Institute of Oncology, Milan

All Listed Sponsors
lead

European Institute of Oncology

OTHER